<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="review-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Terapevticheskii arkhiv</journal-id><journal-title-group><journal-title xml:lang="en">Terapevticheskii arkhiv</journal-title><trans-title-group xml:lang="ru"><trans-title>Терапевтический архив</trans-title></trans-title-group></journal-title-group><issn publication-format="print">0040-3660</issn><issn publication-format="electronic">2309-5342</issn><publisher><publisher-name xml:lang="en">LLC Obyedinennaya Redaktsiya</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">551833</article-id><article-id pub-id-type="doi">10.26442/00403660.2023.05.202273</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Reviews</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Обзоры</subject></subj-group><subj-group subj-group-type="article-type"><subject>Review Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">The use of sodium hyaluronate to treat upper limb disease: A review</article-title><trans-title-group xml:lang="ru"><trans-title>Использование натрия гиалуроната для терапии заболеваний верхних конечностей</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-3024-9483</contrib-id><name-alternatives><name xml:lang="en"><surname>Filatova</surname><given-names>Yulia S.</given-names></name><name xml:lang="ru"><surname>Филатова</surname><given-names>Юлия Сергеевна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="ru"><p>кандидат медицинских наук, доцент кафедры терапии имени Е.Н. Дормидонтова Института непрерывного последипломного образования</p></bio><email>y.s.filatova@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-6278-374X</contrib-id><name-alternatives><name xml:lang="en"><surname>Ilyin</surname><given-names>Mikhail V.</given-names></name><name xml:lang="ru"><surname>Ильин</surname><given-names>Михаил Витальевич</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="ru"><p>доктор медицинских наук, профессор заведующий кафедрой терапии имени Е.Н. Дормидонтова Института непрерывного последипломного образования</p></bio><email>y.s.filatova@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Yaroslavl State Medical University</institution></aff><aff><institution xml:lang="ru">ФГБОУ ВО «Ярославский государственный медицинский университет» Минздрава России</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2023-07-16" publication-format="electronic"><day>16</day><month>07</month><year>2023</year></pub-date><volume>95</volume><issue>5</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>438</fpage><lpage>443</lpage><history><date date-type="received" iso-8601-date="2023-07-16"><day>16</day><month>07</month><year>2023</year></date><date date-type="accepted" iso-8601-date="2023-07-16"><day>16</day><month>07</month><year>2023</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2023, Consilium Medicum</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2023, ООО "Консилиум Медикум"</copyright-statement><copyright-year>2023</copyright-year><copyright-holder xml:lang="en">Consilium Medicum</copyright-holder><copyright-holder xml:lang="ru">ООО "Консилиум Медикум"</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by-nc-sa/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://ter-arkhiv.ru/0040-3660/article/view/551833">https://ter-arkhiv.ru/0040-3660/article/view/551833</self-uri><abstract xml:lang="en"><p>The most common diseases of the upper limb are osteoarthritis (OA) of the joints of the hands, lateral epiconlitis, tendinitis of the shoulder muscles, adhesive capsulitis. OA of the shoulder and acromioclavicular joints is less common. The development of acute and subacute pain in the elbow and shoulder joints in the vast majority of cases is determined by the pathology of soft tissues: muscles, ligamentous apparatus and related synovial bags, making it difficult to diagnose. A clinical and radiological heterogeneity of OA of the joints of the hands is a very complex pathology for the study, and also to create a unified algorithms for therapy. Therapy nonsteroidal anti-inflammatory drugs are effective in the short term, but it has several side effects. Despite a variety of attempts at therapy with successful and unsuccessful outcome, the attention of researchers for several decades converted to the injection therapy with hyaluronic acid. The article presents the data of studies demonstrating the anti-inflammatory effect of hyaluronic acid in the treatment of OA, as well as the results of clinical trials and data system of meta-analysis demonstrating the effectiveness of intra-articular and extra-articular therapy tendinopathy of the upper limb. Most of the cited studies demonstrated the efficacy and good tolerance of 1% sodium hyaluronate. In the domestic market it is presented in the drug Flexotron Forte. The authors provide the results of the study results, demonstrating the efficacy and safety of using Flexotron Forte to clinical practice.</p></abstract><trans-abstract xml:lang="ru"><p>Самыми распространенными заболеваниями верхней конечности являются остеоартрит (ОА) суставов кистей, латеральный эпикондилит, тендинит мышц плеча, адгезивный капсулит. Реже встречаются ОА плечевого и акромиально-ключичного суставов. Развитие острой и подострой боли в локтевом и плечевом суставах в подавляющем большинстве случаев определяется патологией мягких тканей: мышц, связочного аппарата и связанных с ним синовиальных сумок, что затрудняет диагностику, а клиническая и рентгенологическая неоднородность ОА суставов кистей является очень сложной патологией для изучения, а также для создания единых алгоритмов терапии. Терапия нестероидными противовоспалительными препаратами эффективна в краткосрочной перспективе, но имеет ряд побочных эффектов. Несмотря на разнообразие попыток терапии с успешным и неуспешным исходом, внимание исследователей уже несколько десятилетий обращено на инъекционную терапию гиалуроновой кислотой. В статье приведены данные исследований, доказывающие противовоспалительное действие гиалуроновой кислоты в терапии ОА, а также результаты клинических исследований и данных системных метаанализов, демонстрирующие эффективность внутрисуставной и околосуставной терапии тенденопатий верхней конечности. Большинство цитируемых исследований продемонстрировали эффективность и хорошую переносимость 1% гиалуроната натрия. На отечественном рынке он представлен препаратом Флексотрон Форте 3 младший Авторами приводятся результаты исследований, демонстрирующие эффективность и безопасность использования Флексотрон Форте 1%, 3 мл в клинической практике</p></trans-abstract><kwd-group xml:lang="en"><kwd>Osteoarthritis</kwd><kwd>hyaluronic acid</kwd><kwd>intra-articular administration of hyaluronic acid in osteoarthritis of the joints of the hands</kwd><kwd>tendency</kwd><kwd>epicondylitis</kwd><kwd>tendinit of the rotator cuff</kwd><kwd>acromioclavicular osteoarthritis</kwd><kwd>Flextron Forte</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>остеоартрит</kwd><kwd>гиалуроновая кислота</kwd><kwd>внутрисуставное введение гиалуроновой кислоты</kwd><kwd>остеоартрит суставов кистей</kwd><kwd>тендениты</kwd><kwd>эпикондилит</kwd><kwd>тенденит вращательной манжеты</kwd><kwd>акромиально-ключичный остеоартрит</kwd><kwd>Флексотрон Форте 1%, 3 мл</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Burbank K, Stevenson J, Czarneck G, Dorfman J. Chronic Shoulder Pain: Part I. Evaluation and Diagnosis. Am Fam Physician. 2008;77(4):453-600.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Meislin RJ, Sperling JW, Stitik TP. Persistent shoulder pain: epidemiology, pathophysiology, and diagnosis. Am J Orthop (Belle Mead NJ). 2005;34(12 Suppl.):5-9.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Shiri R, Viikari-Juntura E, Varonen H, Heliövaara M. Prevalence and determinant soflateral and medialepicondylitis: apopulation study. Am J Epidemiol. 2006;164(11):1065-74. DOI:10.1093/aje/kwj325</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Long H, Liu Q, Yin H, et al. Prevalence Trends of Site-Specific Osteoarthritis From 1990 to 2019: Findings From the Global Burden of Disease Study 2019. Arthritis Rheumatol. 2022;74(7):1172-83. DOI:10.1002/art.42089</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Molnar V, Matišić V, Kodvanj I, et al. Cytokines and Chemokines Involved in Osteoarthritis Pathogenesis. Int J Mol Sci. 2021;22(17):9208. DOI:10.3390/ijms22179208</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Fioravanti A, Tenti S, McAllister M, et al. Exploring the Involvement of NLRP3 and IL-1β in Osteoarthritis of the Hand: Results from a Pilot Study. Mediators Inflamm. 2019;2019:2363460. DOI:10.1155/2019/2363460</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Oo WM, Little C, Duong V, Hunter DJ. The Development of Disease-Modifying Therapies for Osteoarthritis (DMOADs): The Evidence to Date. Drug Des Devel Ther. 2021;15:2921-45. DOI:10.2147/DDDT.S295224</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Kingsbury SR, Tharmanathan P, Keding A, et al. Hydroxychloroquine effectiveness in reducing symptoms of hand osteoarthritis: a randomized trial. Ann Intern Med. 2018;168(6):385-95. DOI:10.7326/M17-1430</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Chevalier X, Ravaud P, Maheu E, et al. Adalimumab in patients with hand osteoarthritis refractory to analgesics and NSAIDs: a randomised, multicentre, doubleblind, placebo-controlled trial. Ann Rheum Dis. 2015;74(9):1697-705. DOI:10.1136/annrheumdis-2014-205348</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Cooper MS. Glucocorticoids in bone and joint disease: the good, the bad and the uncertain. Clin Med (Lond). 2012;12(3):261-5. DOI:10.7861/clinmedicine.12-3-261</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Altman RD, Manjoo A, Fierlinger A, et al. The mechanism of action for hyaluronic acid treatment in the osteoarthritic knee: a systematic review. BMC Musculoskelet Disord. 2015;16:321. DOI:10.1186/s12891-015-0775-z</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Yasuda T. Hyaluronan inhibits prostaglandin E2 production via CD44 in U937 human macrophages. Tohoku J Exp Med. 2010;220(3):229-35. DOI:10.1620/tjem.220.229</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Sasaki A, Sasaki K, Konttinen YT, et al. Hyaluronate inhibits the interleukin-1beta-induced expression of matrix metalloproteinase (MMP)-1 and MMP-3 in human synovial cells. Tohoku J Exp Med. 2004;204(2):99-107. DOI:10.1620/tjem.204.99</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Fuchs S, Mönikes R, Wohlmeiner A, Heyse T. Intra-articular hyaluronic acid compared with corticoid injections for the treatment of rhizarthrosis. Osteoarthritis Cartilage. 2006;14(1):82-8. DOI:10.1016/j.joca.2005.07.016</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Monfort J, Rotés-Sala D, Segalés N, et al. Comparative efficacy of intra-articular hyaluronic acid and corticoid injections in osteoarthritis of the first carpometacarpal joint: results of a 6-month single-masked randomized study. Joint Bone Spine. 2015;82(2):116-21. DOI:10.1016/j.jbspin.2014.08.008</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Heyworth BE, Lee JH, Kim PD, et al. Hylan versus corticosteroid versus placebo for treatment of basal joint arthritis: a prospective, randomized, double-blinded clinical trial. J Hand Surg Am. 2008;33(1):40-8. DOI:10.1016/j.jhsa.2007</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Figen Ayhan F, Ustün N. The evaluation of efficacy and tolerability of Hylan G-F 20 in bilateral thumb base osteoarthritis: 6 months follow-up. Clin Rheumatol. 2009;28(5):535-41. DOI:10.1007/s10067-008-1080-0</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Abdelsabor Sabaah HM, El Fattah RA, Al Zifzaf D, Saad H. A Comparative Study for Different Types of Thumb Base Osteoarthritis Injections: A Randomized Controlled Interventional Study. Ortop Traumatol Rehabil. 2020;22(6):447-54. DOI:10.5604/01.3001.0014.6055</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Conrozier T, Monfort J, Chevalier X, et al. EUROVISCO Recommendations for Optimizing the Clinical Results of Viscosupplementation in Osteoarthritis. Cartilage. 2020;11(1):47-59. DOI:10.1177/1947603518783455</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Migliore A, Gigliucci G, Alekseeva L, et al. Systematic Literature Review and Expert Opinion for the Use of Viscosupplementation with Hyaluronic Acid in Different Localizations of Osteoarthritis. Orthop Res Rev. 2021;13:255-73. DOI:10.2147/ORR.S336185</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Филатова Ю.С., Соловьев И.Н. Гиалуроновая кислота в лечении остеоартрита различных локализаций. Обзор литературы. Терапевтический архив. 2022;94(8):1014-9 [Filatova YS, Soloviev IN. Hyaluronic acid in the treatment of osteoarthritis of various localization: A review. Terapevticheskii Arkhiv (Ter. Arkh.). 2022;94(8):1014-9 (in Russian)]. DOI:10.26442/00403660.2022.08.201790</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>Шостак Н. А., Правдюк Н.Г., Тимофеев В. Т., и др. Патология плечевого сустава и мягких тканей – клинические варианты, современные возможности патогенетической терапии. Клиницистарший 2021;15(1–4)–К652 [Shostak NA, Pravdyuk NG, Timofeev VT, et al. Pathology of the shoulder joint and soft tissues: Clinical variants, current capabilities of pathogenesis-directed therapy. The Clinician. 2021;15(1–4)–К652 (in Russian)]. DOI:10.17650/1818-8338-2021-15-1-4-К652</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>Frizziero A, Salamanna F, Della Bella E, et al. The Role of Detraining in Tendon Mechanobiology. Front Aging Neurosci. 2016;8:43. DOI:10.3389/fnagi.2016.00043</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation>Oliva F, Piccirilli E, Berardi AC, et al. Hormones and tendinopathies: The current evidence. Br Med Bull. 2016;117:39-58. DOI:10.1093/bmb/ldv054</mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation>Del Buono A, Battery L, Denaro V, et al. Tendinopathy and inflammation: Some truths. Int J Immunopathol Pharm. 2011;24:45-50. DOI:10.1177/03946320110241S209</mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation>Tallon C, Maffulli N, Ewen SW. Ruptured Achilles tendons are significantly more degenerated than tendinopathic tendons. Med Sci Sports Exerc. 2001;33:1983-90. DOI:10.1097/00005768-200112000-00002</mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation>Maganaris CN, Narici MV, Almekinders LC, Maffulli N. Biomechanics and pathophysiology of overuse tendon injuries: Ideas on insertional tendinopathy. Sports Med. 2004;34:1005-17. DOI:10.2165/00007256-200434140-00005</mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation>Chisari E, Rehak L, Khan WS, Maffulli N. Tendon healing in presence of chronic low-level inflammation: A systematic review. Br Med Bull. 2019;132:97-116. DOI:10.1093/bmb/ldz035</mixed-citation></ref><ref id="B29"><label>29.</label><mixed-citation>Kulkarni R, Gibson J, Brownson P, et al. Subacromial shoulder pain. Shoulder Elbow. 2015;7(2):135-43. DOI:10.1177/1758573215576456</mixed-citation></ref><ref id="B30"><label>30.</label><mixed-citation>Cummins CA, Sasso LM, Nicholson D. Impingement syndrome: temporal outcomes of nonoperative treatment. J Shoulder Elbow Surg. 2009;18(2):172-7. DOI:10.1016/j.jse.2008.09.00</mixed-citation></ref><ref id="B31"><label>31.</label><mixed-citation>Ciardulli MC, Marino L, Lovecchio J, et al. Tendon and Cytokine Marker Expression by Human Bone Marrow Mesenchymal Stem Cells in a Hyaluronate/Poly-Lactic-Co-Glycolic Acid (PLGA)/Fibrin Three-Dimensional (3D) Scaffold. Cells. 2020;9:1268. DOI:10.3390/cells9051268</mixed-citation></ref><ref id="B32"><label>32.</label><mixed-citation>Esenyel CZ, Tekin C, Cakar M, et al. Surgical treatment of the neglected achilles tendon rupture with Hyalonect. J Am Podiatr Med Assoc. 2014;104:434-43. DOI:10.7547/0003-0538-104.5.434</mixed-citation></ref><ref id="B33"><label>33.</label><mixed-citation>St Onge R, Weiss C, Denlinger JL, Balazs EA. A preliminary assessment of Na-hyaluronate injection into "no man's land" for primary flexor tendon repair. Clin Orthop Relat Res. 1980;146:269-75.</mixed-citation></ref><ref id="B34"><label>34.</label><mixed-citation>Yuzawa K. Experimental studies on the healing and restoration of gliding function of the injured digital flexor tendon. Part 9: The use of drugs to prevent adhesion formation of the injured tendon. Nihon Seikeigeka Gakkai Zasshi. 1985;59(12):1107-18 (in Japanes).</mixed-citation></ref><ref id="B35"><label>35.</label><mixed-citation>Nakamura H, Gotoh M, Kanazawa T, et al. Effects of corticosteroids and hyaluronic acid on torn rotator cuff tendons in vitro and in rats. J Orthop Res. 2015;33:1523-30. DOI:10.1002/jor.22921</mixed-citation></ref><ref id="B36"><label>36.</label><mixed-citation>Frizziero A, Vittadini F, Barazzuol M, et al. Extracorporeal shockwaves therapy versus hyaluronic acid injection for the treatment of painful non-calcific rotator cuff tendinopathies: Preliminary results. J Sports Med Phys Fit. 2017;57:1162-8. DOI:10.23736/S0022-4707.16.06408-2</mixed-citation></ref><ref id="B37"><label>37.</label><mixed-citation>Wiig M, Abrahamsson SO, Lundborg G. Effects of hyaluronan on cell proliferation and collagen synthesis: A study of rabbit flexor tendons in vitro. J Hand Surg Am. 1996;21:599-604. DOI:10.1016/S0363-5023(96)80010-4</mixed-citation></ref><ref id="B38"><label>38.</label><mixed-citation>Dean BJ, Franklin SL, Carr AJ. A systematic review of the histological and molecular changes in rotator cuff disease. Bone Joint Res. 2012;1:158-66. DOI:10.1302/2046-3758.17.2000115</mixed-citation></ref><ref id="B39"><label>39.</label><mixed-citation>Osti L, Berardocco M, di Giacomo V, et al. Hyaluronic acid increases tendon derived cell viability and collagen type I expression in vitro: Comparative study of four different Hyaluronic acid preparations by molecular weight. BMC Musculoskelet. Disord. 2015;16:284. DOI:10.1186/s12891-015-0735-7</mixed-citation></ref><ref id="B40"><label>40.</label><mixed-citation>Ozgenel GY, Etoz A. Effects of repetitive injections of hyaluronic acid on peritendinous adhesions after flexor tendon repair: A preliminary randomized, placebo-controlled clinical trial. Ulus Travma Acil Cerrahi Derg. 2012;18:11-7. DOI:10.5505/tjtes.2012.95530</mixed-citation></ref><ref id="B41"><label>41.</label><mixed-citation>Kaux JF, Samson A, Crielaard JM. Hyaluronic acid and tendon lesions. Muscles Ligaments Tendons J. 2015;5:264-9. DOI:10.32098/mltj.04.2015.02</mixed-citation></ref><ref id="B42"><label>42.</label><mixed-citation>Yamamoto A, Takagishi K, Osawa T, et al. Prevalence and risk factors of a rotator cuff tear in the general population. J Shoulder Elb Surg. 2010;19:116-20. DOI:10.1016/j.jse.2009.04.006</mixed-citation></ref><ref id="B43"><label>43.</label><mixed-citation>Meloni F, Milia F, Cavazzuti M, et al. Clinical evaluation of sodium hyaluronate in the treatment of patients with sopraspinatus tendinosis under echographic guide: Experimental study of periarticular injections. Eur J Radiol. 2008;68:170-3. DOI:10.1016/j.ejrad.2007.11.001</mixed-citation></ref><ref id="B44"><label>44.</label><mixed-citation>Flores C, Balius R, Alvarez G, et al. Efficacy and Tolerability of Peritendinous Hyaluronic Acid in Patients with Supraspinatus Tendinopathy: A Multicenter, Randomized, Controlled Trial. Sports Med Open. 2017;3:22. DOI:10.1186/s40798-017-0089-9</mixed-citation></ref><ref id="B45"><label>45.</label><mixed-citation>Petrella RJ, Cogliano A, Decaria J, et al. Management of Tennis Elbow with sodium hyaluronate periarticular injections. Sports Med Arthrosc Rehabil Ther Technol. 2010;2:4. DOI:10.1186/1758-2555-2-4</mixed-citation></ref><ref id="B46"><label>46.</label><mixed-citation>Khan IU, Awan AS, Khan AS, et al. Efficacy Of A Single-Injection Sodium Hyaluronate Treatment In Lateral Epicondylitis. J Ayub Med Coll Abbottabad. 2018;30:85-9.</mixed-citation></ref><ref id="B47"><label>47.</label><mixed-citation>Tosun HB, Gumustas S, Agir I, et al. Comparison of the effects of sodium hyaluronate-chondroitin sulphate and corticosteroid in the treatment of lateral epicondylitis: A prospective randomized trial. J Orthop Sci. 2015;20:837-43. DOI:10.1007/s00776-015-0747-z</mixed-citation></ref><ref id="B48"><label>48.</label><mixed-citation>Precerutti M, Formica M, Bonardi M, et al. Acromioclavicular osteoarthritis and shoulder pain: a review of the role of ultrasonography. J Ultrasound. 2020;23(3):317-25. DOI:10.1007/s40477-020-00498-z</mixed-citation></ref><ref id="B49"><label>49.</label><mixed-citation>Zhang B, Thayaparan A, Horner N, et al. Outcomes of hyaluronic acid injections for glenohumeral osteoarthritis: a systematic review and meta-analysis. J Shoulder Elbow Surg. 2019;28(3):596-606. DOI:10.1016/j.jse.2018.09.011</mixed-citation></ref><ref id="B50"><label>50.</label><mixed-citation>Беляева И.Б. Современная концепция локальной инъекционной терапии остеоартрита и заболеваний околосуставных мягких тканей: фокус на препараты гиалуроновой кислоты (Флексотрон Форте). Эффективная фармакотерапия. 2022;18(29):6-12 [Belyayeva IB. Modern Concept of Local Injection Therapy of Osteoarthritis and Diseases of the Periarticular Soft Tissues: Focus on Hyaluronic Acid Preparations (Flexotron Forte). Effektivnaia farmakoterapiia. 2022;18(29):6-12 (in Russian)]. DOI:10.33978/2307-3586-2022-18-10</mixed-citation></ref><ref id="B51"><label>51.</label><mixed-citation>Беляева Е.А., Фатенко А.С., Авдеева О.С., Беляева С.В. Сравнительная эффективность внутрисуставного введения препаратов гиалуроновой кислоты с различными физико-химическими свойствами при остеоартрите коленного сустава. Современная ревматология. 2021;15(6):48-54 [Belyaeva EA, Fatenko AS, Avdeeva OS, Belyaeva SV. Comparative effectiveness of intra-articular administration of different drugs of hyaluronic acid with various physico-chemical properties in knee osteoarthritis. Modern Rheumatology Journal. 2021;15(6):48-54 (in Russian)]. DOI:10.14412/1996-7012-2021-6-48-54</mixed-citation></ref><ref id="B52"><label>52.</label><mixed-citation>Попов В.П., Корощенко С.А., Ларин М.А. Оптимальное использование препаратов гиалуроновой кислоты при суставной патологии. РМЖ. Медицинское обозрение. 2017;1(1):12-4. Режим доступа: https://www.rmj.ru/articles/revmatologiya/Optimalynoe_ispolyzovanie_preparatov_gialuronovoy_kisloty_pri_sustavnoy_patologii/#ixzz83vbmpryq. Ссылка активна на 22.06.2023 [Popov VP, Koroshchenko SA, Larin MA. Optimal use of hyaluronic acid for joint pathology treatment. RMJ. Medical Review. 20171(1):12-4. Available at: https://www.rmj.ru/articles/revmatologiya/Optimalynoe_ispolyzovanie_preparatov_gialuronovoy_kisloty_pri_sustavnoy_patologii/#ixzz83vbmpryq. Accessed: 22.06.2023 (in Russian)].</mixed-citation></ref><ref id="B53"><label>53.</label><mixed-citation>Призов А.П., Загородний Н.В., Лазко Ф.Л., и др. Сравнение реологических и вязкоупругих свойств медицинских изделий гиалуроновой кислоты для внутрисуставного введения. Современная ревматология. 2023;17(2):50-6 [Prizov AP, Zagorodniy NV, Lazko FL, et al. Comparison of rheological and viscoelastic properties of hyaluronic acid for intraarticular injections. Modern Rheumatology Journal. 2023;17(2):50-6 (in Russian)]. DOI:10.14412/1996-7012-2023-2-50-56.</mixed-citation></ref></ref-list></back></article>
